trial

Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)

NCTId NCT00885690
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 11 (actual)
Sponsored by University of Aarhus
Primary completion 2012-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
11 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-04
Primary completion
2012-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
SertindoleOlanzapine

Sponsors

University of AarhusLead Sponsor
Aalborg Psychiatric HospitalCollaborator
Malmö UniversityCollaborator

Investigators

1
René S. Kahn, M.D., Ph.D.Principal Investigator

Sites

2 total
Aalborg, DenmarkMalmö, Sweden

Facts & assertions

4 sourced
Enrollment
11
Phase
NA
Primary Completion Date
2012-11
Status
TERMINATED
relationships
The graph out of here
drug
Sertindole
drug
Olanzapine
drug
lead_sponsor
University of Aarhus
company
collaborator
Aalborg Psychiatric Hospital
company
Malmö University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
René S. Kahn, M.D., Ph.D.
person